Description
Bio-Rad Laboratories: Is The Growth in Digital PCR Business Here To Stay?
Bio-Rad Laboratories Inc.’s (Bio-Rad) second quarter of 2025 results reflect a blend of stability and adverse challenges. The company reported net sales of approximately $652 million, a 2.1% increase from the previous year on a reported basis, though just a 1% rise when adjusted for currency fluctuations. This performance was largely buoyed by robust sales in the Life Sciences segment, particularly in process chromatography and food safety products.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
